| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/11/1998 | CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
| 06/11/1998 | CA2273199A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 06/11/1998 | CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
| 06/11/1998 | CA2272848A1 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof |
| 06/11/1998 | CA2272821A1 Methods of preserving prokaryotic cells and compositions obtained thereby |
| 06/10/1998 | EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae |
| 06/10/1998 | EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae |
| 06/10/1998 | EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family |
| 06/10/1998 | EP0846762A2 Novel V31 seven transmembrane receptors |
| 06/10/1998 | EP0846760A1 Production and use of anthelmintic agents and protective immunogens |
| 06/10/1998 | EP0846700A1 Pollen Allergens |
| 06/10/1998 | EP0846468A1 Non-virulent mycoplasma synoviae and vaccine thereof |
| 06/10/1998 | EP0846181A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 06/10/1998 | EP0846178A1 Allergen-xcd32 fusion proteins |
| 06/10/1998 | EP0846176A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
| 06/10/1998 | EP0846174A1 Methods for enhancing the production of interferon in cell culture |
| 06/10/1998 | EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/10/1998 | EP0846171A2 Chromosome 1 gene and gene products related to alzheimer's disease |
| 06/10/1998 | EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
| 06/10/1998 | EP0846160A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 06/10/1998 | EP0845997A1 Stabile isotonic lyophilized protein formulation |
| 06/10/1998 | EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
| 06/10/1998 | EP0750644B1 Water insoluble cross-linked polycarbonic acid compositions |
| 06/10/1998 | EP0721346B1 Methods for inducing antigen-specific t cell tolerance |
| 06/10/1998 | EP0500699B1 Cross-protective salmonella vaccines |
| 06/10/1998 | EP0487627B1 Wound healing preparations containing heparanase |
| 06/10/1998 | DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation |
| 06/10/1998 | CN1184531A Method for diagnosing a patient for chlamydia |
| 06/10/1998 | CN1184505A Vaccines for plague |
| 06/10/1998 | CN1184484A Novel anti-AIDS immunotoxins |
| 06/10/1998 | CN1184431A Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
| 06/10/1998 | CN1184420A Production scale method of forming microparticles |
| 06/10/1998 | CN1184158A Type 1V collagenase-resisting single stranded antibody |
| 06/09/1998 | US5763574 HIV-specific synthetic antigens and their use |
| 06/09/1998 | US5763572 HTLV-II peptide antigens |
| 06/09/1998 | US5763571 Amino acid sequences which inhibit binding |
| 06/09/1998 | US5763433 Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof |
| 06/09/1998 | US5763396 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 06/09/1998 | US5763284 Methods for peptide synthesis and purification |
| 06/09/1998 | US5763274 Antibody 103B2 |
| 06/09/1998 | US5763272 Amino acid sequence of cells for monoclonal antibodies |
| 06/09/1998 | US5763269 Recombinant infectious bovine rhinotrocheitis virus |
| 06/09/1998 | US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus |
| 06/09/1998 | US5763214 Fibroblast growth factor 11 |
| 06/09/1998 | US5763195 Method and compositions for making ACSF and ACSF antagonists |
| 06/09/1998 | US5763164 Immunogenic cancer proteins and peptides and methods of use |
| 06/09/1998 | US5763160 Detecting antibodies to hiv and neutralizing antibodies to hiv-gp120 in an immunoassay by using polypeptide or conjugate of polypeptide, polylysine of peptide 127 or mixtures |
| 06/09/1998 | US5763159 Hepatitis-C virus testing |
| 06/09/1998 | US5762943 And deacylated monophosphoryl lipid, carrier, and allergen |
| 06/09/1998 | US5762941 Modified shigella having reduced pathogenicity |
| 06/09/1998 | US5762939 Method for producing influenza hemagglutinin multivalent vaccines using baculovirus |
| 06/09/1998 | US5762938 Modified recombinant vaccinia virus and expression vectors thereof |
| 06/09/1998 | US5762934 Clostridium difficile toxin disease therapy |
| 06/09/1998 | US5762932 Inhibiting tumor growth |
| 06/09/1998 | US5762927 Exposing primate to immunotoxin, administering lymph node lymphocytes, transplanting organ |
| 06/09/1998 | US5762921 Composition and methods for the treatment of tumors |
| 06/09/1998 | US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 06/04/1998 | WO1998023960A1 Assay method for peptide specific t-cells |
| 06/04/1998 | WO1998023959A2 Diagnosis and treatment of insulin-dependent diabetes mellitus |
| 06/04/1998 | WO1998023763A1 Heterologous antigens in live cell v. cholerae strains |
| 06/04/1998 | WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 06/04/1998 | WO1998023754A1 Process for the expression of genes of the dengue viruses |
| 06/04/1998 | WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
| 06/04/1998 | WO1998023745A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 06/04/1998 | WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof |
| 06/04/1998 | WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 06/04/1998 | WO1998023735A1 Immune responses using compositions containing stress proteins |
| 06/04/1998 | WO1998023640A1 Procedure for the purification and refolding of hpv proteins |
| 06/04/1998 | WO1998023635A1 Novel promiscuous t helper cell epitopes |
| 06/04/1998 | WO1998023631A1 Novel bacterial polypeptides and polynucleotides |
| 06/04/1998 | WO1998023288A1 A vaccine composition comprising helicobacter pylori flagellin polypeptide |
| 06/04/1998 | WO1998023287A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
| 06/04/1998 | WO1998023282A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 06/04/1998 | WO1998023279A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 06/04/1998 | WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 06/04/1998 | WO1998011919A3 Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof |
| 06/04/1998 | CA2274143A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof |
| 06/04/1998 | CA2272632A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
| 06/04/1998 | CA2272536A1 Immune responses using compositions containing stress proteins |
| 06/04/1998 | CA2272243A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 06/04/1998 | CA2270283A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 06/04/1998 | CA2253244A1 A vaccine composition comprising helicobacter pylori flagellin polypeptide |
| 06/03/1998 | EP0845540A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same |
| 06/03/1998 | EP0845537A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1998 | EP0845535A2 Leader peptidase (lep) from Streptococcus |
| 06/03/1998 | EP0845531A2 Polypeptides and polynucleotides from the Staphylococcus SigB operon |
| 06/03/1998 | EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library |
| 06/03/1998 | EP0845270A1 Functional fragment antigen of tetanus toxin and tetanus vaccine |
| 06/03/1998 | EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 06/03/1998 | EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 06/03/1998 | EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof |
| 06/03/1998 | EP0845007A2 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 06/03/1998 | EP0844885A2 Chemical compounds |
| 06/03/1998 | EP0844883A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma |
| 06/03/1998 | EP0358692B1 Cholera vaccines |
| 06/03/1998 | CN1183811A Method for isolation and purification of lipid cell-wall components |
| 06/03/1998 | CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies |
| 06/03/1998 | CN1038559C Method for preparing vaccine against E coli septicaemia in poultry |
| 06/02/1998 | US5760185 Anti-feline herpes virus-1 recombinant antibody and gene fragment coding for said antibody |
| 06/02/1998 | US5760178 Antitumor |